Europe (English)  Francaise  Italiano  Svenska  Dansk

Banner1int

 

Search

  

 

RSS feed RSS feed (English)

 

Home

 

International courses

Compliance Seminars®

Webinars

 

Play4GMP®

The GMP board game that tests and improves your GMP compliance, knowledge, attitude and awareness!

 

Courses in local languages

Français

Italiano

Svenska

Dansk

 

Literature

Collection of GMP's for pharmaceutical production

The GMP Handbook for pharmaceuticals

Quality Systems Handbook for MedDev

E-books: US and EU regulations

QSIT

Basic statistics for QC-Lab

ICH Q8, Q9, Q10

GMP translations (FR, IT, SE, DK)

 

Consulting

 

KEY2GMP®

Search tool and document library. Find your way in regulations, guides and other reference documents.

 

Newsletter

Subscribe / unsubscribe

 

Other

About us

Contact

Suggestion Box

Site map

Links

Course venues

Affiliates

Policys and Cookies

GMP Compliance and Auditing for Biopharmaceutical/Biologic APIs

Industry field:

Biopharmaceutical industry

 

Course description:

Recent FDA Warning Letters stress the reality that compliance requirements for biopharmaceuticals/biologics are different and more stringent than traditional pharmaceuticals. Biopharmaceutical/Biologic firms face a host of unique compliance issues, particularly given the fact that microorganisms can degrade biopharmaceutical/biologic products. In addition, industry trends toward the use of contract and/or multi-product manufacturing emphasizes the need for personnel to better understand these evolving regulatory compliance expectations. This course reviews and interprets the specific GMP requirements from FDA for biopharmaceuticals/biologic Active Pharmaceutical Ingredients (APIs), provides a foundation for compliance personnel and auditors to focus on the most critical compliance problems, and offers suggestions for effective quality systems.

 

This two-day course reviews the applicable FDA regulations and guidance documents including the ICH Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (Q7). Interpretation of the regulatory expectations is facilitated through a review of relevant FDA Warning Letters, 483 observations, typical inspector questions, and current industry standards. Case studies are offered throughout the course to more effectively integrate the principles presented.

 

Who should attend:

This course is designed to provide a basic overview of critical regulatory compliance issues specific to Active Pharmaceutical Ingredient (API) biopharmaceutical/biologics, based on ICH Q7 and an FDA perspective. Personnel in QA, QC, Regulatory, and Manufacturing involved in ensuring GMP compliance and/or performing compliance audits should attend. Course assumes the attendee has a basic understanding of the GMP regulations.

 

Learning objectives:

This course is designed to provide an introductory overview and interpretation of FDA compliance requirements specific to manufacturing Active Pharmaceutical Ingredient (API) biopharmaceuticals/biologics based on ICH Q7 and other relevant FDA and ICH guidance documents. One of the primary goals of the course is to provide the attendee sufficient understanding of the most critical regulatory inspection issues in order to be able to participate in building effective compliance programs and/or perform effective compliance audits.

 

Course outline:

  • Introduction
    • Course Strategy
    • Structure of FDA
    • GMP Principles
    • Regulatory Documents
  • Facilities and Environmental Monitoring
    • Facility Design
      • Regulatory Guidance
      • Multi-product Facility Considerations
    • Environmental Monitoring
      • Area Classifications
      • Sampling and Testing Programs
      • Limits
      • Investigations
      • Trending
    • Case Study: Facility Flow Diagram and Area Classification
  • Manufacturing Compliance
    • Fermentation/Cell Culture
      • Transfers and Feeds
      • In Process Monitoring
      • Trending
    • Recovery/Cell Processing
      • Centrifugation
      • Filtration
      • Capture Chromatography
    • Purification
      • Viral Inactivation
      • Chromatography
      • Ultrafiltration/Diafiltration
    • API Handling
    • General Topics
      • Filtration
      • Media/Buffer/Solution Prep
      • In-Process Testing
      • Double Checks
      • Cleaning Issues
      • Use of Disposables
    • Contamination Control and Process Bioburden Monitoring
  • Raw Material Compliance
    • Contamination Control
    • Critical Materials
    • Materials Control
    • Supplier Qualification
  • Cleaning Validation/Verification
    • Cleaning Procedures
    • Sampling and Testing Methods
    • Acceptance Limits
    • Special Considerations for Multi-product facilities
      • Routine Monitoring
      • Cleaning Verification
    • Changeover
    • Case Study: Understanding Acceptance Limits
  • Process Validation
    • Definitions
    • New FDA Guidance
    • Process Validation Program Documentation
    • Quality by Design (QbD)
    • Biotechnology Product-Specific Support Studies
    • Continued Process Verification
    • Case Study: Evaluating Parameters
  • Cell Banking
    • Introduction
    • Why High Level of Compliance
    • Facilities and Equipment
    • Raw Materials
    • Manufacturing
    • Testing
    • Storage and Access

 

 

Course facts

Course No:

5310

Instructor:

Mr. John Bennan

Next course:

Authumn 2012.

Stockholm, Sweden

Course venue:

-

Agenda:

Day 1: 08.30-17.00

(Registration 08.00-08.30)
Day 2: 8.30-17.00

Price:

€ 1.895 incl. course material, lunches and refreshments

Discounts:

We do not offer any general discounts. Instead we will always offer best value courses for good value fees to ALL our attendees. For larger groups we can offer discounts based on case by case discussions, please contact for quotation. We do not offer or practise any general company discounts without commitments and/or written agreements.

Cancellation policy:

Registration is binding and when you have received our confirmation the following conditions are know and accepted. If you for any reason is unable to attend, substitution is always possible and preferred.

All cancellations and/or substitutions must have been communicated with and confirmed by us.

Cancellations received less than 21 calendar days before course start are subjected to a service charge of 200 € (Euro). Cancellations received less than 7 calendar days prior the course, or failure to cancel or "no-show", will be charged in full.

Courses may be cancelled by the organizer if bookings fail to reach minimum numbers, and in such circumstances course fees will be refunded, or granted to attend another course for the same value. We are not responsible or liable to any costs in conjunction with a cancelled course. Under normal conditions a cancellation decision is taken +6 weeks prior the course start.

spacer